Ovarian Cancer Coverage from Every Angle
Advertisement
Advertisement


Isabelle Ray-Coquard, MD, PhD, on the Safety of Combination Regimens With Bevacizumab

Posted: Monday, September 30, 2019

Does the combination of a PARP inhibitor and bevacizumab require special monitoring regarding safety?